alexa Oral SMAD7 Antisense Oligonucleotide: A Novel Agent for Management of Crohn's Disease | OMICS International| Abstract

Journal of Molecular Immunology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • J Mol Immunol 2017, Vol 1(1): e104

Oral SMAD7 Antisense Oligonucleotide: A Novel Agent for Management of Crohn's Disease

Divey M*, Chandrasekar T and Sandeep V
Upstate Medical University, Syracuse, NY, , United States
*Corresponding Author : Divey M, Upstate Medical University, Syracuse, United States, Tel: 315 4648668, Email: [email protected]

Received Date: Nov 21, 2015 / Accepted Date: Nov 24, 2015 / Published Date: Nov 28, 2015

Citation: Divey M, Chandrasekar T, Sandeep V (2015) Oral SMAD7 Antisense Oligonucleotide: A Novel Agent for Management of Crohn’s Disease. J Mol Immunol 2:e104.

Copyright: © 2015 Divey M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 8766
  • [From(publication date): 12-2017 - Jul 13, 2020]
  • Breakdown by view type
  • HTML page views: 8642
  • PDF downloads: 124
Top